🇺🇸 FDA
Patent

US 7045535

Compounds useful for inhibiting paramyxovirus neuraminidase

expired A61KA61K31/351A61K31/381

Quick answer

US patent 7045535 (Compounds useful for inhibiting paramyxovirus neuraminidase) held by BioCryst Pharmaceuticals, Inc. expires Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue May 16 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 11 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K31/351, A61K31/381, A61K31/4025, A61K31/4178